← Back to Vaccine Database

COMIRNATY

RNA based vaccine · VDDBV0166

Target & Classification

SARS-CoV-2SARS-CoV-2
RNA based vaccine
Covid19; Severe Acute Respiratory Syndrome
ApprovedPhase 4 reached

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT04760132 ApprovedCovid19; Severe Acute Respiratory Syndrome